Propensity-adjusted 8-year outcomes following bioprosthetic aortic valve replacement: The influence of novel anticalcification technologyCentral MessagePerspective

Objective: Aortic bioprostheses with RESILIA (Edwards Lifesciences) tissue technology have demonstrated robust outcomes through 7 years of follow-up. However, studies comparing RESILIA tissue valve outcomes to previous bioprosthetic valves are lacking. We sought to assess surgical aortic valve repla...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Tsuyoshi Kaneko, MD, Joseph E. Bavaria, MD, Vinod H. Thourani, MD, Douglas R. Johnston, MD
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Elsevier 2026-02-01
Cyfres:	JTCVS Open
Pynciau:	aortic valve replacement aortic valve disease bioprosthetic valve RESILIA tissue long-term durability
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S2666273625004887
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!